Literature DB >> 17699273

Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?

Kirsten Brukamp1, Alden M Doyle, Roy D Bloom, Nancy Bunin, John E Tomaszewski, Borut Cizman.   

Abstract

Glomerular disease associated with nephrotic syndrome has rarely been recognized as a distinct complication of allogeneic hematopoietic cell transplantation. Case reports in the English and Japanese literature since 1988 have described variable glomerular histology, comprising mainly membranous glomerulonephritis (MGN) in almost two thirds and minimal change disease (MCD) in nearly one quarter of patients. Review of the literature reveals a close temporal relationship between the development of nephrotic syndrome shortly after cessation of immunosuppression and the diagnosis of chronic graft-versus-host disease (GVHD). An association of glomerular disease with simultaneous GVHD was seen in 47% of patients overall. Nephrotic syndrome followed GVHD within 5 months in 60% of the combined MCD and MGN reports. A decrease in immunosuppressive medication use was linked to nephrotic syndrome occurrence within 9 months in 63% of patients with MCD and MGN. MCD occurred earlier after hematopoietic cell transplantation, was diagnosed sooner after medication change, and exhibited a better prognosis in comparison with MGN. Glomerular lesions after hematopoietic cell transplantation may therefore represent the renal manifestation of GVHD. Further studies are warranted to delineate the pathogenesis of this complication.

Entities:  

Mesh:

Year:  2006        PMID: 17699273     DOI: 10.2215/CJN.00380705

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  42 in total

Review 1.  Acute kidney injury in HCT: an update.

Authors:  J A Lopes; S Jorge; M Neves
Journal:  Bone Marrow Transplant       Date:  2016-02-08       Impact factor: 5.483

Review 2.  Onco-nephrology: AKI in the cancer patient.

Authors:  Albert Q Lam; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

3.  Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes.

Authors:  B Dhakal; A Singavi; E P Cohen; M Dangal; J Palmer; A Dall; A D'Souza; M Hamadani; P N Hari
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

4.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

Review 5.  Kidney diseases associated with haematological cancers.

Authors:  Anirban Ganguli; Deirdre Sawinski; Jeffrey S Berns
Journal:  Nat Rev Nephrol       Date:  2015-06-02       Impact factor: 28.314

6.  Early occurrence of nephrotic syndrome associated with cord blood stem cell transplantation.

Authors:  Kenichiro Miura; Takashi Sekine; Masaru Takamizawa; Hiroshi Terashima; Ayaka Furuya; Katsuyoshi Koh; Junko Takita; Kohmei Ida; Takashi Igarashi
Journal:  Clin Exp Nephrol       Date:  2011-10-12       Impact factor: 2.801

Review 7.  Renal dysfunction following bone marrow transplantation.

Authors:  Stephan Kemmner; Mareike Verbeek; Uwe Heemann
Journal:  J Nephrol       Date:  2016-09-02       Impact factor: 3.902

Review 8.  A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

Authors:  Sonata Jodele; Benjamin L Laskin; Christopher E Dandoy; Kasiani C Myers; Javier El-Bietar; Stella M Davies; Jens Goebel; Bradley P Dixon
Journal:  Blood Rev       Date:  2014-11-28       Impact factor: 8.250

9.  Long-term remission of HSCT-related NS after a second allogenic stem cell transplant.

Authors:  Shogo Kobayashi; Yukihiko Kawasaki; Hideki Sano; Kazuhiro Mochizuki; Mitsuaki Hosoya; Atsushi Kikuta
Journal:  Pediatr Nephrol       Date:  2015-12-11       Impact factor: 3.714

10.  Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival.

Authors:  Sangeeta R Hingorani; Kristy Seidel; Armando Lindner; Tia Aneja; Gary Schoch; George McDonald
Journal:  Biol Blood Marrow Transplant       Date:  2008-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.